Abiopharma

Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

(10% Negative) ALDEYRA THERAPEUTICS, INC. (ALDX) Announces Delay in modulator Trials for proof-of-concept clinical testing Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review

Castle Biosciences to Participate in Upcoming Investor Conferences

Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity

Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025

Alkermes plc Reports Third Quarter 2025 Financial Results

Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025

Entrada Therapeutics to Present at Upcoming Investor Conferences

Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

IQVIA Reports Third-Quarter 2025 Results

New Form 10-Q - REGENERON PHARMACEUTICALS, INC. Filed: 2025-10-28 AccNo: 0000872589-25-000028 Size: 8 MB

(10% Negative) LABCORP HOLDINGS INC. (LH) Announces Business Combination

New Form 10-Q - GeneDx Holdings Corp. Filed: 2025-10-28 AccNo: 0001818331-25-000130 Size: 8 MB